The Latin America, Middle East and Africa Wearable Patch Market is expected to witness market growth of 11.1% CAGR during the forecast period (2020-2026).
Wearable patches cab be attached to the skin. It can be worn for some hours to a few weeks. These patches are nowadays gaining more and more attention that can be used for drug delivery, sports, or patient monitoring. These patches are also used for the delivery of medication and treatment such as anti-aging patches and nicotine. The Regular Wearable patches have wireless connectivity in addition to the features that a Connected Wearable patches have. These help in checking the health of an individual and to deliver drugs accordingly.
It is noted that there is increasing number of diagnostic tests due to outbreak of COVID-19 has led to in the necessity for incorporation of these data into health information systems (HIS). The growing incidences of chronic diseases and the increasing geriatric population in turn has resulted in the rise in the number of diagnostic procedures that are performed globally. Sensor patches are nowadays being acknowledged in the healthcare sector for diagnostics applications because the current and historical data that are collected by sensor patches support clinicians with exact diagnostics. The opportunity for diagnostics sensor patches in childcare is rising because infants cannot talk about their health status.
Based on Technology, the market is segmented into Connected Wearable and Regular Wearable. Based on Application, the market is segmented into Non-Clinical and Clinical. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DexCom, Inc., Abbott Laboratories, Koninklijke Philips N.V., Smith & Nephew PLC (Leaf Healthcare, Inc.), Qualcomm, Inc., L'Oreal Group, VivaLNK, Inc., Cardiac Insight, Inc., AliveCor, Inc. and LifeSignals Group, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
By Application
By Country
Companies Profiled
Unique Offerings
Wearable patches cab be attached to the skin. It can be worn for some hours to a few weeks. These patches are nowadays gaining more and more attention that can be used for drug delivery, sports, or patient monitoring. These patches are also used for the delivery of medication and treatment such as anti-aging patches and nicotine. The Regular Wearable patches have wireless connectivity in addition to the features that a Connected Wearable patches have. These help in checking the health of an individual and to deliver drugs accordingly.
It is noted that there is increasing number of diagnostic tests due to outbreak of COVID-19 has led to in the necessity for incorporation of these data into health information systems (HIS). The growing incidences of chronic diseases and the increasing geriatric population in turn has resulted in the rise in the number of diagnostic procedures that are performed globally. Sensor patches are nowadays being acknowledged in the healthcare sector for diagnostics applications because the current and historical data that are collected by sensor patches support clinicians with exact diagnostics. The opportunity for diagnostics sensor patches in childcare is rising because infants cannot talk about their health status.
Based on Technology, the market is segmented into Connected Wearable and Regular Wearable. Based on Application, the market is segmented into Non-Clinical and Clinical. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include DexCom, Inc., Abbott Laboratories, Koninklijke Philips N.V., Smith & Nephew PLC (Leaf Healthcare, Inc.), Qualcomm, Inc., L'Oreal Group, VivaLNK, Inc., Cardiac Insight, Inc., AliveCor, Inc. and LifeSignals Group, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Technology
- Connected Wearable
- Regular Wearable
By Application
- Non-Clinical
- Clinical
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- DexCom, Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
- Smith & Nephew PLC (Leaf Healthcare, Inc.)
- Qualcomm, Inc.
- L'Oreal Group
- VivaLNK, Inc.
- Cardiac Insight, Inc.
- AliveCor, Inc.
- LifeSignals Group, Inc.
Unique Offerings
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. LAMEA Wearable Patch Market by Technology
Chapter 5. LAMEA Wearable Patch Market by Application
Chapter 6. LAMEA Wearable Patch Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- DexCom, Inc.
- Abbott Laboratories
- Koninklijke Philips N.V.
- Smith & Nephew PLC (Leaf Healthcare, Inc.)
- Qualcomm, Inc.
- L'Oreal Group
- VivaLNK, Inc.
- Cardiac Insight, Inc.
- AliveCor, Inc.
- LifeSignals Group, Inc.
Methodology
LOADING...
